Novo Nordisk News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.09.16	Novo Nordisk: Lars Fruergaard Jørgensen To Succeed Lars Rebien Sørensen As CEO (RTTNews)
05.08.16	Novo Nordisk H1 Profit Rises, To Pay Dividend; Cuts FY16 Growth View (RTTNews)
14.06.16	Novo Nordisk: Victoza Reduces Risk Of Heart Attack In People With Type2 Diabetes (RTTNews)
24.05.16	EXEL Rises On Trial Data, XNPT Agrees To Be Acquired, NVO Faces FDA Panel Today (RTTNews)
01.05.16	Biotech Stocks Facing FDA Decision In May (RTTNews)
29.04.16	Novo Nordisk Q1 Profit Decreases; Affirms 2016 Outlook (RTTNews)
28.04.16	Novo Nordis: Semaglutide Reduces Risk Of Major Adverse Cardiovascular Events (RTTNews)
29.03.16	Novo Nordisk Breaks Ground On $2 Bln Production Unit In Clayton, North Carolina (RTTNews)
03.02.16	Novo Nordisk 2015 Profit Rises - Quick Facts (RTTNews)
28.09.15	Opdivo In The Headlines, Lightlake On Course, FDA Approves 2 Diabetes Drugs (RTTNews)
26.09.15	Diabetes Drugs Tresiba, Ryzodeg Finally Reach FDA Finish Line (RTTNews)
07.09.15	Novo Nordisk To Buy Back Shares Worth 17.5 Bln Danish Kroner (RTTNews)
14.08.15	Genmab Grants Licenses For DuoBody Technology Platform To Novo Nordisk (RTTNews)
06.07.15	Novo Nordisk Plans To Discontinue GLP-1 Patch Collaboration With Zosano Pharma (RTTNews)
08.04.15	Novo Nordisk: FDA Accepts For Review Class II Resubmissions For Tresiba, Ryzodeg (RTTNews)
27.03.15	Novo Nordisk Plans To Resubmit NDAs Of Tresiba And Ryzodeg In US (RTTNews)
25.03.15	Novo Nordisk: Final Trials Of Faster-Acting Insulin Aspart Meet Primary Point (RTTNews)
24.03.15	Bristol-Myers Acquires License For Discovery Research Program From Novo Nordisk (RTTNews)
23.03.15	Novo Nordisk: Saxenda Approved In Europe To Treat Obesity (RTTNews)
30.01.15	Novo Nordisk 2014 Profit Rises - Quick Facts (RTTNews)
23.01.15	ADXS In Focus, EGLT Soars, NEO Boosts Outlook, RMD Hits Record High (RTTNews)
22.01.15	Novo Nordisk Gets Positive CHMP Opinion For Obesity Drug Saxenda (RTTNews)
24.12.14	FDA Approves Novo Nordisk's Obesity Drug Saxenda (RTTNews)
12.09.14	U.S. FDA Panel Urges Approval Of Novo Nordisk Injection For Obesity (RTTNews)
02.09.14	Novo Nordisk Terminates R&D Activities Within Inflammatory Disorders (RTTNews)
07.08.14	Novo Nordisk H1 Profit Up - Quick Facts (RTTNews)
19.03.14	Novo Nordisk: First Phase 3 Trial With N8-GP Shows Positive Results (RTTNews)
24.12.13	FDA Approves Novo's Tretten For Rare Clotting Disorder (RTTNews)
20.12.13	Novo Nordisk Files Liraglutide For Regulatory Approval For Obesity (RTTNews)
10.12.13	Novo Nordisk Reported To Police For Violation Of Disclosure Obligation (RTTNews)
31.10.13	Novo Nordisk 9-month Profit Rises - Quick Facts (RTTNews)
10.10.13	Critical Alerts For Baidu.com, Home Depot, GenCorp, Novo Nordisk, and Silver Wheaton Released By InvestorsObserver (PR Newswire)
09.10.13	Drug Approvals, Data Presentations, Clinical Trials, New Appointments, and Corporate Events - Research Report on Johnson & Johnson, Novo Nordisk, Isis, Keryx, and The Medicines Company (PR Newswire)
30.09.13	Product Launches, Clinical Study Results, Historical Trials, Joint Lawsuits and Milestone Patient Enrollment - Research Report on Teva, Pacira, Novo Nordisk, Forest, and Amarin (PR Newswire)
08.08.13	Novo Nordisk Q2 Profit Climbs; Lifts FY13 Growth Forecast - Quick Facts (RTTNews)
07.08.13	Critical Alerts For Starbucks, Nordstrom, Novo Nordisk, MannKind, and Westport Innovations Released By InvestorsObserver (PR Newswire)
02.08.13	Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In Rochester, Minnesota As Part Of Educational Initiative (PR Newswire)
01.08.13	/K I L L K I L L K I L L - Novo Nordisk/ (PR Newswire)
01.08.13	Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In Seattle As Part Of Educational Initiative (PR Newswire)
29.05.09	Novo Nordisk: New study directly comparing insulin delivery devices shows that Next Generation FlexPen® has a significantly lower injection force than SoloStar® and KwikPen® (Businesswire)
31.01.07	Novo Nordisk Announces Financial Statement for 2006 (PR Newswire)
18.04.06	Dana Haza Joins Novo Nordisk as Senior Director of the National Changing Diabetes Program (PR Newswire)
15.12.05	Neose and Novo Nordisk Expand Agreement (PR Newswire)
10.11.05	Novo Nordisk Becomes Insulin Market Leader (PR Newswire)
02.11.05	Novo Nordisk Appoints Christopher Porter as Director of Government Affairs in the United States (PR Newswire)
17.06.05	FDA Approves Levemir(R) (insulin detemir [rDNA Origin] Injection) - a New, Long-Acting Insulin Treatment for Diabetes (PR Newswire)
06.06.05	Winners of First Shock Society/Novo Nordisk Research Grant for Haemorrhagic Shock and Haemostasis are Announced (PR Newswire)
09.03.05	Novo Nordisk A/S AGM Statement (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nestle	74.20	0.13 %	K V
Swiss Life Hldg	689.40	0.06 %	K V
Kuehne+Nagel Int	202.30	0.00 %	K V
Swisscom	501.50	-0.30 %	K V
Swiss Re	129.10	-0.39 %	K V
Logitech Intl	73.02	-2.41 %	K V
Roche Hldg G	246.70	-3.25 %	K V
UBS Group	26.89	-3.34 %	K V
Part Grp Hldg	1’217.00	-4.29 %	K V
ABB	48.73	-5.42 %	K V

Nachrichten zu Novo Nordisk (spons. ADRs)

Aktien Top/Flop

Novo Nordisk Peer Group Nachrichten

Meistgelesene Nachrichten